A bivalent form of a RBD-specific synthetic antibody effectively neutralizes SARS-CoV-2 variants.
Kim DG, Kim U, Park IH, Ryu B, Yoo Y, Cha JS, Yoon GY, Kim SH, Oh H, Seo JY, Nam KT, Seong JK, Shin JS, Cho HS, Kim HS.
Kim DG, et al. Among authors: kim u, kim sh, kim hs.
Antiviral Res. 2023 Dec;220:105738. doi: 10.1016/j.antiviral.2023.105738. Epub 2023 Nov 8.
Antiviral Res. 2023.
PMID: 37944822